Clinical Trial Update: Effect of Oxytocin Antagonist on Reduction of Uterine Contractions [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an oxytocin receptor antagonist for reducing uterine contractions in patients undergoing in vitro fertilization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Oxytocin receptor antagonist (atosiban)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: In Vitro Fertilisation (IVF) Treatment | Phase 2 | Status: COMPLETED